Skip to main content
Clinical Trials/JPRN-UMIN000025053
JPRN-UMIN000025053
Completed
未知

Development of measuring method to monitor progression of cognitive decline and its improvement by intervention in dementia and mild cognitive impairment (MCI). - Development of measuring method to monitor progression of cognitive decline and its improvement by intervention in dementia and mild cognitive impairment (MCI).

niversity of Tsukuba Hospital0 sites60 target enrollmentDecember 1, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
mild cognitive impairment:MCI frontotemporal dementia:FTD
Sponsor
niversity of Tsukuba Hospital
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Tsukuba Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1Parkinson'disease, multiple cerebral infarction, Huntington's disease, normal pressure hydrocephalus, brain tumor, progressive supranuclear palsy, epilepsy, subdural hematoma, multiple sclerosis, head trauma with sequelae 2Signs of brain infection, focal brain lesions(eg infarction)that may affect cognitive function. 3Presence of pacemaker, arterial clip, artificial valves, artificial cochlea, and other magnetic/electroconductive metals in the body that may affect MRI 4Major depression or bipolar disorder within past 1 year, addiction to alcohol or other drugs within past 2 years, presence of fatal or unstable diseases, vitamin B12 or folate deficiency, syphilis, thyroid function abnormality 5Administration of psychoactive drugs (defined in procedure manual) 6Administration of warfarin 7Participant in clinical trial of new AD therapeutic drug 8Clinical Judgment Committee 9Participant with impaired AD

Outcomes

Primary Outcomes

Not specified

Similar Trials